These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 33032207)
1. Comparison of the diagnostic accuracy of diffusion-weighted and dynamic contrast-enhanced MRI with Diez AIG; Fuster D; Morata L; Torres F; Garcia R; Poggio D; Sotes S; Del Amo M; Isern-Kebschull J; Pomes J; Soriano A; Brugnara L; Tomas X Eur J Radiol; 2020 Nov; 132():109299. PubMed ID: 33032207 [TBL] [Abstract][Full Text] [Related]
2. Utility of PET/CT with fluorine-18-fluorodeoxyglucose-labeled autologous leukocytes for diagnosing diabetic foot osteomyelitis in patients with Charcot's neuroarthropathy. Rastogi A; Bhattacharya A; Prakash M; Sharma S; Mittal BR; Khandelwal N; Bhansali A Nucl Med Commun; 2016 Dec; 37(12):1253-1259. PubMed ID: 27749777 [TBL] [Abstract][Full Text] [Related]
3. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection? Basu S; Chryssikos T; Houseni M; Scot Malay D; Shah J; Zhuang H; Alavi A Nucl Med Commun; 2007 Jun; 28(6):465-72. PubMed ID: 17460537 [TBL] [Abstract][Full Text] [Related]
4. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
5. Multiparametric functional MRI and Martens RM; Koopman T; Lavini C; Ali M; Peeters CFW; Noij DP; Zwezerijnen G; Marcus JT; Vergeer MR; Leemans CR; de Bree R; de Graaf P; Boellaard R; Castelijns JA Eur Radiol; 2021 Feb; 31(2):616-628. PubMed ID: 32851444 [TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced MRI versus Feng F; Qiang F; Shen A; Shi D; Fu A; Li H; Zhang M; Xia G; Cao P Chin J Cancer Res; 2018 Feb; 30(1):21-30. PubMed ID: 29545716 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography for the diagnosis of osteomyelitis related to diabetic foot: a systematic review and a meta-analysis. Treglia G; Sadeghi R; Annunziata S; Zakavi SR; Caldarella C; Muoio B; Bertagna F; Ceriani L; Giovanella L Foot (Edinb); 2013 Dec; 23(4):140-8. PubMed ID: 23906976 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms. Armbruster M; Zech CJ; Sourbron S; Ceelen F; Auernhammer CJ; Rist C; Haug A; Singnurkar A; Reiser MF; Sommer WH J Magn Reson Imaging; 2014 Aug; 40(2):457-66. PubMed ID: 24347148 [TBL] [Abstract][Full Text] [Related]
10. Gastric cancer and image-derived quantitative parameters: Part 2-a critical review of DCE-MRI and Tang L; Wang XJ; Baba H; Giganti F Eur Radiol; 2020 Jan; 30(1):247-260. PubMed ID: 31392480 [TBL] [Abstract][Full Text] [Related]
11. [ Jin Y; Huang K; Shao T Clin Radiol; 2024 Sep; 79(9):e1142-e1151. PubMed ID: 38880677 [TBL] [Abstract][Full Text] [Related]
12. Diagnosing osteomyelitis in diabetic foot by diffusion-weighted imaging and dynamic contrast material-enhanced magnetic resonance imaging: a systematic review and meta-analysis. Wudhikulprapan W; Phinyo P; Hadi A; Kanthawang T; Choudur HN Clin Radiol; 2024 Nov; 79(11):805-817. PubMed ID: 39168784 [TBL] [Abstract][Full Text] [Related]
13. Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot? Familiari D; Glaudemans AW; Vitale V; Prosperi D; Bagni O; Lenza A; Cavallini M; Scopinaro F; Signore A J Nucl Med; 2011 Jul; 52(7):1012-9. PubMed ID: 21680679 [TBL] [Abstract][Full Text] [Related]
15. FDG PET/CT imaging in the diagnosis of osteomyelitis in the diabetic foot. Kagna O; Srour S; Melamed E; Militianu D; Keidar Z Eur J Nucl Med Mol Imaging; 2012 Oct; 39(10):1545-50. PubMed ID: 22801731 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic performances of FDG-PET/CT and diffusion-weighted imaging indices for differentiating benign pheochromocytoma from other benign adrenal tumors. Nakajo M; Nakajo M; Fukukura Y; Jinguji M; Shindo T; Nakabeppu Y; Kamimura K; Yoneyama T; Takumi K; Yoshiura T Abdom Imaging; 2015 Aug; 40(6):1655-65. PubMed ID: 25382022 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Performance of Dynamic Contrast-Enhanced MRI and Zhang Y; Zhao H; Liu Y; Zeng M; Zhang J; Hao D Acad Radiol; 2022 Dec; 29(12):1842-1851. PubMed ID: 35396157 [TBL] [Abstract][Full Text] [Related]
18. The utility of ADC value in diffusion-weighted whole-body MRI in the follow-up of patients with multiple myeloma. Correlation study with Paternain A; García-Velloso MJ; Rosales JJ; Ezponda A; Soriano I; Elorz M; Rodríguez-Otero P; Aquerreta JD Eur J Radiol; 2020 Dec; 133():109403. PubMed ID: 33202373 [TBL] [Abstract][Full Text] [Related]
19. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma. Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of diffusion-weighted imaging and Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]